EJHaem · Oct 28, 2026

Nodal T Follicular Helper Cell Lymphoma With Epstein-Barr Virus-Positive Neoplastic T Cells Derived From Clonal Hematopoiesis

By Kishi D, Hiramoto N, Yamashita D et al.

INTRODUCTION: Nodal T follicular helper cell lymphoma (nTFHL) with Epstein-Barr virus (EBV)-positive neoplastic T cells is rare. METHODS: We report a woman with nTFHL and analyzed EBV-infected cells using an immunobead-based method and assessed somatic mutations in lymphoma and lymphoma-uninvolved bone marrow by targeted sequencing. RESULTS: EBV DNA was enriched in the CD4-positive fraction containing neoplastic T cells. Shared TET2 mutation was identified in both lymphoma and bone marrow, whereas additional TET2 and RHOA G17V mutations were restricted to the lymphoma. CONCLUSION: These findings support a stepwise model of EBV-positive nTFHL arising from TET2-mutated clonal hematopoiesis with subsequent acquisition of a RHOA mutation. TRIAL REGISTRATION: The authors have confirmed clinical trial registration is not needed for this submission.

doi.org/10.1002/jha2.70449Open accessPubMed 42959303Mechanisms

AgingResearch.News